JP2013535508A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535508A5 JP2013535508A5 JP2013524253A JP2013524253A JP2013535508A5 JP 2013535508 A5 JP2013535508 A5 JP 2013535508A5 JP 2013524253 A JP2013524253 A JP 2013524253A JP 2013524253 A JP2013524253 A JP 2013524253A JP 2013535508 A5 JP2013535508 A5 JP 2013535508A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cancer
- tumor
- virus
- melanoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 claims 53
- 108091007433 antigens Proteins 0.000 claims 53
- 102000036639 antigens Human genes 0.000 claims 53
- 108090000765 processed proteins & peptides Proteins 0.000 claims 16
- 239000012634 fragment Substances 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 15
- 201000001441 melanoma Diseases 0.000 claims 12
- 241000725303 Human immunodeficiency virus Species 0.000 claims 10
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 239000002671 adjuvant Substances 0.000 claims 10
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims 8
- 102000007066 Prostate-Specific Antigen Human genes 0.000 claims 8
- 239000000556 agonist Substances 0.000 claims 8
- 230000000890 antigenic effect Effects 0.000 claims 7
- 229960005486 vaccine Drugs 0.000 claims 7
- 102100028667 C-type lectin domain family 4 member A Human genes 0.000 claims 6
- 101000766908 Homo sapiens C-type lectin domain family 4 member A Proteins 0.000 claims 6
- 102000002689 Toll-like receptor Human genes 0.000 claims 6
- 108020000411 Toll-like receptor Proteins 0.000 claims 6
- 102100035526 B melanoma antigen 1 Human genes 0.000 claims 4
- -1 CD31 Proteins 0.000 claims 4
- 108010040721 Flagellin Proteins 0.000 claims 4
- 101710154606 Hemagglutinin Proteins 0.000 claims 4
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 claims 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 4
- 241000701806 Human papillomavirus Species 0.000 claims 4
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims 4
- 102100022430 Melanocyte protein PMEL Human genes 0.000 claims 4
- 108010063954 Mucins Proteins 0.000 claims 4
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 4
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 4
- 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 claims 4
- 101710199789 Oxidized low-density lipoprotein receptor 1 Proteins 0.000 claims 4
- 101710176177 Protein A56 Proteins 0.000 claims 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 4
- 239000000185 hemagglutinin Substances 0.000 claims 4
- 208000032839 leukemia Diseases 0.000 claims 4
- 108700025647 major vault Proteins 0.000 claims 4
- 210000002307 prostate Anatomy 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- FFILOTSTFMXQJC-QCFYAKGBSA-N (2r,4r,5s,6s)-2-[3-[(2s,3s,4r,6s)-6-[(2s,3r,4r,5s,6r)-5-[(2s,3r,4r,5r,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(e)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hy Chemical compound O[C@@H]1[C@@H](O)[C@H](OCC(NC(=O)CCCCCCCCCCCCCCCCC)C(O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@@H]([C@@H](N)[C@H](O)C2)C(O)C(O)CO[C@]2(O[C@@H]([C@@H](N)[C@H](O)C2)C(O)C(O)CO)C(O)=O)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 FFILOTSTFMXQJC-QCFYAKGBSA-N 0.000 claims 2
- 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 claims 2
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 2
- 102000015735 Beta-catenin Human genes 0.000 claims 2
- 108060000903 Beta-catenin Proteins 0.000 claims 2
- 208000018084 Bone neoplasm Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 102100028668 C-type lectin domain family 4 member C Human genes 0.000 claims 2
- 102100028672 C-type lectin domain family 4 member D Human genes 0.000 claims 2
- 102100028681 C-type lectin domain family 4 member K Human genes 0.000 claims 2
- 101710183165 C-type lectin domain family 4 member K Proteins 0.000 claims 2
- 102100040840 C-type lectin domain family 7 member A Human genes 0.000 claims 2
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims 2
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims 2
- 102100032912 CD44 antigen Human genes 0.000 claims 2
- 102100035793 CD83 antigen Human genes 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 108010060385 Cyclin B1 Proteins 0.000 claims 2
- 108090000259 Cyclin D Proteins 0.000 claims 2
- 102000003910 Cyclin D Human genes 0.000 claims 2
- 241000701022 Cytomegalovirus Species 0.000 claims 2
- 208000002699 Digestive System Neoplasms Diseases 0.000 claims 2
- 101150029707 ERBB2 gene Proteins 0.000 claims 2
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 claims 2
- 102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 claims 2
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 claims 2
- 208000017604 Hodgkin disease Diseases 0.000 claims 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 2
- 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 claims 2
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 claims 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 2
- 101000766907 Homo sapiens C-type lectin domain family 4 member C Proteins 0.000 claims 2
- 101000766905 Homo sapiens C-type lectin domain family 4 member D Proteins 0.000 claims 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 2
- 101000946856 Homo sapiens CD83 antigen Proteins 0.000 claims 2
- 101000894906 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Proteins 0.000 claims 2
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims 2
- 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims 2
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 claims 2
- 101000608935 Homo sapiens Leukosialin Proteins 0.000 claims 2
- 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims 2
- 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims 2
- 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 claims 2
- 101001018258 Homo sapiens Macrophage receptor MARCO Proteins 0.000 claims 2
- 101000620359 Homo sapiens Melanocyte protein PMEL Proteins 0.000 claims 2
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims 2
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims 2
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims 2
- 101000980827 Homo sapiens T-cell surface glycoprotein CD1a Proteins 0.000 claims 2
- 101000716149 Homo sapiens T-cell surface glycoprotein CD1b Proteins 0.000 claims 2
- 101000716124 Homo sapiens T-cell surface glycoprotein CD1c Proteins 0.000 claims 2
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims 2
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims 2
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 claims 2
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 2
- 102100022338 Integrin alpha-M Human genes 0.000 claims 2
- 102100025304 Integrin beta-1 Human genes 0.000 claims 2
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims 2
- 102100037850 Interferon gamma Human genes 0.000 claims 2
- 108010074328 Interferon-gamma Proteins 0.000 claims 2
- 102000010789 Interleukin-2 Receptors Human genes 0.000 claims 2
- 108010038453 Interleukin-2 Receptors Proteins 0.000 claims 2
- 241000710842 Japanese encephalitis virus Species 0.000 claims 2
- 102100039564 Leukosialin Human genes 0.000 claims 2
- 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 102100033486 Lymphocyte antigen 75 Human genes 0.000 claims 2
- 101710157884 Lymphocyte antigen 75 Proteins 0.000 claims 2
- 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 claims 2
- 206010025323 Lymphomas Diseases 0.000 claims 2
- 102000043129 MHC class I family Human genes 0.000 claims 2
- 108091054437 MHC class I family Proteins 0.000 claims 2
- 102000043131 MHC class II family Human genes 0.000 claims 2
- 108091054438 MHC class II family Proteins 0.000 claims 2
- 102100033272 Macrophage receptor MARCO Human genes 0.000 claims 2
- 108010031099 Mannose Receptor Proteins 0.000 claims 2
- 241000712079 Measles morbillivirus Species 0.000 claims 2
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims 2
- 208000034578 Multiple myelomas Diseases 0.000 claims 2
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims 2
- 108010006232 Neuraminidase Proteins 0.000 claims 2
- 102000005348 Neuraminidase Human genes 0.000 claims 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims 2
- 102000036673 PRAME Human genes 0.000 claims 2
- 108060006580 PRAME Proteins 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 2
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims 2
- 101710192141 Protein Nef Proteins 0.000 claims 2
- 241000711798 Rabies lyssavirus Species 0.000 claims 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims 2
- 241000725643 Respiratory syncytial virus Species 0.000 claims 2
- 241000702670 Rotavirus Species 0.000 claims 2
- 241000710799 Rubella virus Species 0.000 claims 2
- 241001138501 Salmonella enterica Species 0.000 claims 2
- 241000700584 Simplexvirus Species 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims 2
- 102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 claims 2
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims 2
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims 2
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 2
- 102100039357 Toll-like receptor 5 Human genes 0.000 claims 2
- 102000003425 Tyrosinase Human genes 0.000 claims 2
- 108060008724 Tyrosinase Proteins 0.000 claims 2
- 241000607626 Vibrio cholerae Species 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 210000000013 bile duct Anatomy 0.000 claims 2
- 210000004556 brain Anatomy 0.000 claims 2
- 210000000621 bronchi Anatomy 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 108010025838 dectin 1 Proteins 0.000 claims 2
- 108700004025 env Genes Proteins 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 108700004026 gag Genes Proteins 0.000 claims 2
- 210000000232 gallbladder Anatomy 0.000 claims 2
- GIVLTTJNORAZON-HDBOBKCLSA-N ganglioside GM2 (18:0) Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 GIVLTTJNORAZON-HDBOBKCLSA-N 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 201000010536 head and neck cancer Diseases 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 208000006454 hepatitis Diseases 0.000 claims 2
- 231100000283 hepatitis Toxicity 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 208000037797 influenza A Diseases 0.000 claims 2
- 208000037801 influenza A (H1N1) Diseases 0.000 claims 2
- 108010061181 influenza matrix peptide (58-66) Proteins 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 210000003734 kidney Anatomy 0.000 claims 2
- 210000000867 larynx Anatomy 0.000 claims 2
- 210000000088 lip Anatomy 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 208000014018 liver neoplasm Diseases 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 210000001989 nasopharynx Anatomy 0.000 claims 2
- 210000000653 nervous system Anatomy 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 108700004029 pol Genes Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 102000005962 receptors Human genes 0.000 claims 2
- 108020003175 receptors Proteins 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 201000010740 swine influenza Diseases 0.000 claims 2
- 201000002510 thyroid cancer Diseases 0.000 claims 2
- 229940044616 toll-like receptor 7 agonist Drugs 0.000 claims 2
- 229940044655 toll-like receptor 9 agonist Drugs 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 210000003932 urinary bladder Anatomy 0.000 claims 2
- 208000020416 vascular bone neoplasm Diseases 0.000 claims 2
- 241000271566 Aves Species 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims 1
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 claims 1
- 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 claims 1
- 208000002979 Influenza in Birds Diseases 0.000 claims 1
- 206010062038 Lip neoplasm Diseases 0.000 claims 1
- 241000186781 Listeria Species 0.000 claims 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims 1
- 241000588653 Neisseria Species 0.000 claims 1
- 241000187654 Nocardia Species 0.000 claims 1
- 108010051791 Nuclear Antigens Proteins 0.000 claims 1
- 102000019040 Nuclear Antigens Human genes 0.000 claims 1
- 102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 206010064097 avian influenza Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000003238 esophagus Anatomy 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 claims 1
- 201000011682 nervous system cancer Diseases 0.000 claims 1
- 208000014500 neuronal tumor Diseases 0.000 claims 1
- 208000023983 oral cavity neoplasm Diseases 0.000 claims 1
- 210000003800 pharynx Anatomy 0.000 claims 1
- 208000023974 pharynx neoplasm Diseases 0.000 claims 1
- 210000000664 rectum Anatomy 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 229940118696 vibrio cholerae Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37376310P | 2010-08-13 | 2010-08-13 | |
| US61/373,763 | 2010-08-13 | ||
| PCT/US2011/047633 WO2012021834A1 (en) | 2010-08-13 | 2011-08-12 | Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535508A JP2013535508A (ja) | 2013-09-12 |
| JP2013535508A5 true JP2013535508A5 (enExample) | 2014-09-25 |
Family
ID=45564978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013524253A Pending JP2013535508A (ja) | 2010-08-13 | 2011-08-12 | 抗体付きアジュバントを抗原提示細胞に直接的に標的化することをベースにした新規ワクチンアジュバント |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20120039916A1 (enExample) |
| EP (1) | EP2603235A4 (enExample) |
| JP (1) | JP2013535508A (enExample) |
| KR (1) | KR20130108295A (enExample) |
| CN (1) | CN103328005A (enExample) |
| AR (1) | AR082686A1 (enExample) |
| AU (1) | AU2011289234B2 (enExample) |
| BR (1) | BR112013002940A2 (enExample) |
| CA (1) | CA2807585A1 (enExample) |
| MX (1) | MX2013001527A (enExample) |
| RU (1) | RU2013110889A (enExample) |
| TW (1) | TWI506035B (enExample) |
| WO (1) | WO2012021834A1 (enExample) |
| ZA (1) | ZA201301013B (enExample) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI422594B (zh) | 2007-02-02 | 2014-01-11 | Baylor Res Inst | 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑 |
| CN101820910B (zh) * | 2007-05-03 | 2014-08-06 | 新加坡科技研究局 | 结合细胞内prl-1多肽或prl-3多肽的抗体 |
| TW201247706A (en) * | 2011-03-08 | 2012-12-01 | Baylor Res Inst | Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells |
| US9045542B2 (en) | 2011-08-29 | 2015-06-02 | Baylor Research Institute | Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2) |
| EP2822599A4 (en) * | 2012-03-05 | 2015-12-23 | Univ Duke | VACCINE FORMULATION |
| CN103566377A (zh) * | 2012-07-18 | 2014-02-12 | 上海博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| WO2014031984A1 (en) * | 2012-08-24 | 2014-02-27 | Baylor Research Institute | Immunological detection methods and compositions |
| CN103409451A (zh) * | 2013-06-28 | 2013-11-27 | 扬州维克斯生物科技有限公司 | 一种向树突状细胞dc靶向加载肿瘤抗原肽的方法 |
| EP3013362B1 (en) | 2013-06-28 | 2021-08-04 | Baylor Research Institute | Dendritic cell asgpr targeting immunotherapeutics for multiple sclerosis |
| US10202450B2 (en) | 2013-09-05 | 2019-02-12 | Duke University | Nav 1.7 antibodies and methods of using the same |
| CA2936377A1 (en) | 2014-01-10 | 2015-07-16 | Shanghai Birdie Biotech, Inc. | Compounds and compositions for treating egfr expressing tumors |
| AU2015204503B2 (en) | 2014-01-13 | 2020-07-09 | Baylor Research Institute | Novel vaccines against HPV and HPV-related diseases |
| US20160340439A1 (en) * | 2014-01-22 | 2016-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy |
| CN106659774A (zh) | 2014-05-16 | 2017-05-10 | 贝勒研究院 | 用于治疗自身免疫和炎性病症的方法和组合物 |
| WO2015187637A1 (en) * | 2014-06-02 | 2015-12-10 | Baylor Research Institute | Methods and compositions for treating allergy and inflammatory diseases |
| US9884921B2 (en) | 2014-07-01 | 2018-02-06 | Pfizer Inc. | Bispecific heterodimeric diabodies and uses thereof |
| EP4001311B1 (en) | 2014-07-09 | 2025-11-05 | Birdie Biopharmaceuticals Inc. | Anti-pd-l1/pd-1 combinations for treating tumors |
| CN112546238A (zh) | 2014-09-01 | 2021-03-26 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-pd-l1结合物 |
| CN104689313A (zh) * | 2015-03-04 | 2015-06-10 | 中国科学院海洋研究所 | 大菱鲆cd83分子作为疫苗佐剂的应用 |
| US10624964B2 (en) | 2015-05-01 | 2020-04-21 | The Trustees Of The University Of Pennsylvania | Methods and compositions for stimulating immune response using potent immunostimulatory RNA motifs |
| MA44334A (fr) | 2015-10-29 | 2018-09-05 | Novartis Ag | Conjugués d'anticorps comprenant un agoniste du récepteur de type toll |
| CA3002095A1 (en) * | 2015-11-10 | 2017-05-18 | Yale University | Compositions and methods for treating autoimmune diseases and cancers |
| EP3389707B1 (en) | 2015-12-15 | 2025-08-20 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Immunogenic construct comprising an ebv-cell antigen and a targeting moiety and applications thereof |
| CN115252792A (zh) | 2016-01-07 | 2022-11-01 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-egfr组合 |
| CN115554406A (zh) | 2016-01-07 | 2023-01-03 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-cd20组合 |
| CN115350279A (zh) | 2016-01-07 | 2022-11-18 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-her2组合 |
| IL261188B (en) | 2016-03-04 | 2022-08-01 | Jn Biosciences Llc | An anti-tigit antibody that binds to the tigit polypeptide on one or more amino acid residues |
| IL263616B2 (en) | 2016-07-07 | 2025-01-01 | Univ Leland Stanford Junior | Antibody-adjuvant conjugates |
| WO2018140831A2 (en) * | 2017-01-27 | 2018-08-02 | Silverback Therapeutics, Inc. | Tumor targeting conjugates and methods of use thereof |
| CN108727503A (zh) * | 2017-04-18 | 2018-11-02 | 武汉博沃生物科技有限公司 | VZV重组gE-鞭毛素融合蛋白及其制备方法和应用 |
| CN118515666A (zh) | 2017-04-27 | 2024-08-20 | 博笛生物科技有限公司 | 2-氨基-喹啉衍生物 |
| CA3067268A1 (en) | 2017-06-23 | 2018-12-27 | Birdie Biopharmaceuticals, Inc. | Crystalline resiquimod monosulfate anhydrate and its preparation and uses |
| WO2019006038A1 (en) * | 2017-06-28 | 2019-01-03 | The Board Of Trustees Of The Leland Stanford Junior University | METHODS AND COMPOSITIONS FOR STIMULATING DECTINE 2 AND CANCER IMMUNOTHERAPY |
| US20210369635A1 (en) * | 2017-11-29 | 2021-12-02 | Adaptive Phage Therapeutics, Inc. | Novel methods of vaccination using icosahedral phage |
| WO2019166432A1 (en) * | 2018-02-28 | 2019-09-06 | F. Hoffmann-La Roche Ag | 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancer |
| US20220106566A1 (en) * | 2019-01-22 | 2022-04-07 | The Brigham And Women`S Hospital, Inc. | Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof |
| AU2020241686A1 (en) | 2019-03-15 | 2021-11-04 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting HER2 |
| WO2020193718A1 (en) | 2019-03-27 | 2020-10-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Recombinant proteins with cd40 activating properties |
| US20220298255A1 (en) * | 2019-05-31 | 2022-09-22 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | E-cadherin activating antibodies and uses thereof |
| CN114787181A (zh) * | 2019-11-21 | 2022-07-22 | Inserm(法国国家健康医学研究院) | 用抗pd-1/il-15免疫细胞因子靶向pd-1的新型免疫疗法 |
| US11179473B2 (en) | 2020-02-21 | 2021-11-23 | Silverback Therapeutics, Inc. | Nectin-4 antibody conjugates and uses thereof |
| JP2023525140A (ja) | 2020-05-13 | 2023-06-14 | アンセルム（アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル） | Ｏｘ４０活性化特性を有する組換えタンパク質 |
| JP2023528017A (ja) | 2020-05-26 | 2023-07-03 | アンセルム（アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル） | 重症急性呼吸器症候群コロナウイルス２（ｓａｒｓ－ｃｏｖ－２）ポリペプチドおよびワクチン目的でのその使用 |
| CR20220611A (es) | 2020-06-02 | 2023-06-07 | Arcus Biosciences Inc | Anticuerpos anti-tigit |
| CN116209678A (zh) | 2020-07-01 | 2023-06-02 | 安尔士制药公司 | 抗asgr1抗体缀合物及其用途 |
| CN111850006B (zh) * | 2020-07-27 | 2022-04-22 | 齐鲁工业大学 | 一种适用于低钙离子浓度的纤维小体对接蛋白组合突变体36865及应用 |
| KR20230107260A (ko) | 2020-11-12 | 2023-07-14 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | Sars-cov-2 스파이크 단백질의 수용체-결합 도메인에 접합되거나 융합된 항체, 및 백신 목적을 위한 이의 용도 |
| US11572407B2 (en) * | 2020-11-18 | 2023-02-07 | Pionyr Immunotherapeutics, Inc. | Anti-MARCO antibodies and uses thereof |
| CA3205280A1 (en) | 2020-12-23 | 2022-06-30 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells |
| MX2023008986A (es) | 2021-01-29 | 2023-08-15 | Inst Nat Sante Rech Med | Polipeptidos antigenicos de chlamydia trachomatis y usos de los mismos con fines de vacuna. |
| CN118555970A (zh) * | 2021-11-04 | 2024-08-27 | 总医院有限公司 | 抗间皮素抗体试剂 |
| KR20240103030A (ko) | 2021-11-17 | 2024-07-03 | 인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰 메디칼르 | 범용 사르베코바이러스 백신 |
| WO2024074571A1 (en) | 2022-10-05 | 2024-04-11 | Institut National de la Santé et de la Recherche Médicale | Dc-targeting vaccine against nipah virus infection |
| EP4601682A1 (en) * | 2022-10-13 | 2025-08-20 | The Brigham & Women's Hospital, Inc. | Methods and compositions for improving response to immunotherapy |
| KR102878250B1 (ko) * | 2023-01-11 | 2025-10-31 | 서울대학교산학협력단 | 코리스메이트 뮤테이즈 단백질 또는 이를 암호화하는 폴리뉴클레오티드를 포함하는 암 예방 또는 치료용 조성물 |
| WO2024216189A1 (en) * | 2023-04-13 | 2024-10-17 | The Regents Of The University Of California | Isoform-independent antibodies to lipoprotein(a) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1057915C (zh) * | 1994-09-19 | 2000-11-01 | 中国医学科学院医药生物技术研究所 | 免疫佐剂 |
| TW200303759A (en) * | 2001-11-27 | 2003-09-16 | Schering Corp | Methods for treating cancer |
| US9259459B2 (en) * | 2003-01-31 | 2016-02-16 | Celldex Therapeutics Inc. | Antibody vaccine conjugates and uses therefor |
| WO2007103048A2 (en) * | 2006-03-01 | 2007-09-13 | Regents Of The University Of Colorado | Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| EP2476432B1 (en) * | 2006-03-07 | 2015-08-19 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| BRPI0807160A2 (pt) * | 2007-02-02 | 2018-09-25 | Baylor Res Institute | vacinas baseadas no direcionamento de antígeno ao dcir expresso em células apresentadoras de antígeno |
| TWI423985B (zh) * | 2007-02-23 | 2014-01-21 | Baylor Res Inst | 利用ｄｅｃｔｉｎ-１活化人類抗原呈現細胞之醫療應用 |
| BRPI0820270A2 (pt) * | 2007-11-07 | 2015-06-16 | Celldex Therapeutics Inc | Anticorpo monoclonal, vetor de expressão, célula, conjugado molecular, composição, uso da composição, método para detectar a presença ou ausência de dec-205 em uma amostra biológica, e, uso de um conjugado molecular. |
| ES2685823T3 (es) * | 2008-07-16 | 2018-10-11 | Baylor Research Institute | Anticuerpos antagonistas anti-CD40 |
| JP2012520073A (ja) * | 2009-03-10 | 2012-09-06 | ベイラー リサーチ インスティテュート | 抗原提示細胞ターゲティングワクチン |
| CN105837691B (zh) * | 2009-03-10 | 2021-06-29 | 贝勒研究院 | 靶向抗原呈递细胞的癌症疫苗 |
| EP2406286B1 (en) * | 2009-03-10 | 2016-05-18 | Baylor Research Institute | Anti-cd40 antibodies and uses thereof |
| US20110274653A1 (en) * | 2010-05-07 | 2011-11-10 | Baylor Research Institute | Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells |
-
2011
- 2011-08-12 TW TW100128970A patent/TWI506035B/zh not_active IP Right Cessation
- 2011-08-12 CA CA2807585A patent/CA2807585A1/en not_active Abandoned
- 2011-08-12 CN CN2011800489046A patent/CN103328005A/zh active Pending
- 2011-08-12 RU RU2013110889/10A patent/RU2013110889A/ru unknown
- 2011-08-12 BR BR112013002940A patent/BR112013002940A2/pt not_active IP Right Cessation
- 2011-08-12 KR KR1020137006354A patent/KR20130108295A/ko not_active Withdrawn
- 2011-08-12 JP JP2013524253A patent/JP2013535508A/ja active Pending
- 2011-08-12 MX MX2013001527A patent/MX2013001527A/es not_active Application Discontinuation
- 2011-08-12 EP EP11817128.9A patent/EP2603235A4/en not_active Withdrawn
- 2011-08-12 AR ARP110102955A patent/AR082686A1/es not_active Application Discontinuation
- 2011-08-12 US US13/208,993 patent/US20120039916A1/en not_active Abandoned
- 2011-08-12 AU AU2011289234A patent/AU2011289234B2/en not_active Ceased
- 2011-08-12 WO PCT/US2011/047633 patent/WO2012021834A1/en not_active Ceased
-
2013
- 2013-02-06 ZA ZA2013/01013A patent/ZA201301013B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535508A5 (enExample) | ||
| RU2013110889A (ru) | Новые вакцинные адъюванты на основе адъювантов-антител, нацеливающих непосредственно на антигенпрезентирующие клетки | |
| RU2012152828A (ru) | Опосредованное иммунорецепторами дендритных клеток (dcir) перекрестное примирование cd8+ т клеток человека | |
| US20120231023A1 (en) | Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells | |
| TWI423985B (zh) | 利用ｄｅｃｔｉｎ-１活化人類抗原呈現細胞之醫療應用 | |
| JP6952029B2 (ja) | Ｔ細胞療法用のｔ細胞を調製する方法 | |
| TWI422594B (zh) | 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑 | |
| TWI446921B (zh) | 基於表現於抗原-表現細胞之樹突細胞免疫受體（ｄｃｉｒ）之標的抗原之疫苗 | |
| US20120121592A1 (en) | Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells | |
| WO2004027049B1 (en) | Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells | |
| JP2015071598A5 (enExample) | ||
| JP2017508797A (ja) | Ｔエフェクター細胞の調節性ｔ細胞に対する比を増加するための方法および組成物 | |
| JP2001524928A (ja) | クロスプライミング免疫による天然抗原に特異性を有するｃｔｌの誘導 | |
| Cohen et al. | CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens | |
| CN113797332B (zh) | 用于免疫疗法的组合物和方法 | |
| RU2013121571A (ru) | Композиции и способы профилактики и лечения злокачественных новообразований | |
| CA2830987A1 (en) | Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine | |
| Jemon et al. | An enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy | |
| Gamat-Huber et al. | Treatment combinations with DNA vaccines for the treatment of metastatic castration-resistant prostate cancer (mCRPC) | |
| Sokke Umeshappa et al. | CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination | |
| WO2024246364A1 (en) | Combination containing an mrna vaccine or an mrna encoded therapeutic protein and an immune modulating mrna for improved or reduced immunogenicity to increase efficacy | |
| Park | Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo | |
| JP2023539525A (ja) | 抗体療法 | |
| JP2025531191A (ja) | ナチュラルキラーｔ細胞リガンドおよび抗原を負荷した末梢血単核細胞を含むワクチン | |
| Li et al. | A Novel Antigen Delivery System for Cancer Immunotherapy Using Antigens Linked to Inactivated Salmonella Bacteria |